Pilot study completes

Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion

Claim ID Study 1 Pretest Questionnaire_for distribution

Pilot study completes

OMB: 0910-0849

Document [pdf]
Download: pdf | pdf
Last edited: June 30, 2017

PRETEST QUESTIONNAIRE – STUDY 1
IMPORTANT GENERAL PROGRAMMING NOTES:
 BLACK= Question stems, response options and instructions that are to appear on screen.
 BLUE = Programming notes, skip patterns and logical operators.
 RED= Value names and labels, which are NOT to appear on screen. These correspond to
parameters set in the data shell.
 GREY= Variable names, which will NOT to appear on screen. These correspond to variable
names in the datashell.
[QUOTA REQUIREMENT: Highest education level 20% of the CONSUMER sample for must be
high school graduate or less]
[Screener Intro Screen will be presented here]
[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP S1_C THROUGH S8_C; GO TO S1_P]
[----------------------------------------New Screen----------------------------------------]
[Screener Items – Consumers English-speaking adults in the United States]
[DISPLAY S1_C IF COHORT = 1 ‘Consumer’]
[NUMERICAL FIELD]
S1_C. How old are you? ____

[Consumers be at least 18 to remain Eligible]

[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S1_C _age < 18,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S2_C]
[SINGLE PUNCH]
S2_C. What is your current occupation?
1 Healthcare provider (e.g., physician, nurse, counselor, physical therapist)
2 Pharmaceutical employee (e.g., pharma rep)
3 Market research employee/advertising employee
4 Employee of the Department of Health and Human Services
5 All other occupations
[Consumers must select 5 to remain Eligible]
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S2_C !== 5 ‘All other occupations’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S3_C]
[SINGLE PUNCH]
S3_C. Have you ever had any chronic or long-lasting pain (more than aches and pains that go away
quickly or are minor)?
1
Yes
[Must select 1 to remain Eligible]
2
No
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S3_C !== 1 ‘Yes’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; SKIP S4_C – S6_C, GO TO S7_C]
[SINGLE PUNCH]
S4_C. Did you experience this chronic or long-lasting pain for at least 3 months?

1

Last edited: June 30, 2017

1
2

Yes
No

[Must select 1 to remain Eligible]

[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S4_C !== 1 ‘Yes’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S5_C]
[SINGLE PUNCH]
S5_C. Do you still have this chronic or long-lasting pain?
1
Yes
2
No
[SINGLE PUNCH]
S6_C. Are you currently taking, or have you ever taken, any prescription drug(s) for chronic pain?
1
Currently taking
2
Have taken in the past but not currently taking
3
Have never taken
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S5_C !== 1 ‘Yes’ AND S6_C !==
‘Currently taking’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S7_C]
[SINGLE PUNCH]
S7_C. What is the highest level of school you have completed or the highest degree you have received?
1
Less than high school
2
High school graduate—high school diploma or the equivalent (for example: GED)
3
Some college but no degree
4
Associate degree in college
5
Bachelor’s degree (for example: BA, AB, BS)
6
Advanced or postgraduate degree (for example: Master’s degree, MD, DDS, JD, PhD,
EdD)
[QUOTA REQUIREMENT: IF COHORT = 1 ‘Consumer’, RESPONDENTS WHO SELECT S3_C
= 1 ‘Less than HS’ OR S3_C = 2 ‘HS grad’ MUST COMPRISE 20% OF COMPLETES]
[SINGLE PUNCH]
S8_C. What is your annual household income?
1 Less than $30,000 per year
2 $30,001 to $75,000 per year
3 $75,001 to $150,000 per year
4 More than $150,000 per year
997 Prefer not to answer
[PROGRAMMER: IF COHORT = 1 ‘Consumer’, SKIP S1_P THROUGH S5_P; GO TO S9]
[----------------------------------------New Screen----------------------------------------]
[Screener Items English-speaking PCPs, in the United States]
[DISPLAY S1_P IF COHORT = 2 ‘PCP’]

2

Last edited: June 30, 2017

[SINGLE PUNCH]
S1_P. Which of the following best describes your profession?
1 Medical doctor/physician
 [PCPs must select 1 to remain Eligible]
2 Physician assistant
3 Nurse practitioner
4 Other
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S1_P !== 1 ‘Medical doctor/physician’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; SKIP S2_P, GO TO S3_P]
[DISPLAY S2_P IF S1_P = 1 ‘Medical doctor/physician’]
[SINGLE PUNCH]
S2_P. Do you consider yourself a primary care provider or specialist?
1 Primary care provider
 [PCPs must select 1 to remain Eligible]
2 Specialist
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S2_P !== 1 ‘Primary care provider’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S3_P]
[SINGLE PUNCH]
S3_P. Which of the following best describes your practice?
1 Family practice
 [PCPs must say 1 ‘Family practice’, OR
2 General practice
 2 ‘General practice, OR
3 Internal medicine
 3 ‘Internal medicine’ to remain Eligible]
4 Other
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND (S3_P = 4 ‘Other’),
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S4_P]
[NUMERICAL FIELD; SET RANGE 0 – 100]
S4_P. In a typical week, what percentage of your time is spent on direct patient care, such as seeing
patients and reviewing their medical records? If you are not sure, please provide your best guess.
_____%
 [PCPs must say at least 50% to remain Eligible]
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S4_P < 50,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S5_P]
[MULTIPLE PUNCH]
[PROGRAMMER: Multipunch response items should be saved to dataset as binary variables with
response options: 1=’Selected’ OR 0=’Not selected’.]
S5_P. Do you treat patients with any of the following conditions? Select all that apply.
S5_P_1.
Asthma
S5_P_2.
Obesity
S5_P_3.
Chronic pain  [PCPs must check chronic pain to remain Eligible]
S5_P_4.
High cholesterol
S5_P_5.
Diabetes
S5_P_6.
Allergies
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S5_P_3 !== 1 ‘Selected’,

3

Last edited: June 30, 2017

SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S11; GO TO S9]
[----------------------------------------New screen----------------------------------------]
[SINGLE PUNCH]
S9. What is your gender?
1
Male
2
Female
[SINGLE PUNCH]
S10. Are you:
1
Hispanic or Latino
2
Not Hispanic or Latino
3
Prefer not to answer
[MULTIPLE PUNCH]
[PROGRAMMER: Multi-punch response items should be saved to dataset as binary variables
with response options: 1=’Selected’ OR 0=’Not selected’.]
S11. What is your race? Select all that apply.
S11_1. American Indian or Alaska Native
S11_2. Asian
S11_3. Black or African American
S11_4. Native Hawaiian or other Pacific Islander
S11_5. White
S11_6. Other
S11_7. Prefer not to answer
[If selected, no other options can be selected]
[PROGRAMMER: IF S11_7 = 1 ‘Selected’, DISABLE OPTIONS S11_1 – S11_6]
[----------------------------------------New screen----------------------------------------]
[DISPLAY ‘Thank and Terminate’ IF EFLAG=0 ‘INELIGIBLE]
[Thank and Terminate]
We’re sorry, but you are not eligible for this study. There are many possible reasons why people are not
eligible for this study. These reasons were decided earlier by the researchers. However, thank you for
your interest in this study and for taking the time to answer our questions today.
[IF EFLAG=0 ‘INELIGIBLE, END HERE]
[----------------------------------------New screen----------------------------------------]

4

Last edited: June 30, 2017

[DISPLAY]
Thank you for your interest in this research study. The purpose of the study is to learn more about
prescription drug websites.
You are one of about {IF PRETEST: “600”, IF MAIN STUDY: “1,500“} people in the United States who
are being asked to take a survey about a new prescription drug.
If you agree to participate, you will look at a website for a new prescription drug and then answer some
survey questions about what you saw. Viewing the website and completing the survey will take
approximately 20 minutes.
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
About the Study
This survey is being conducted by RTI International (RTI), an independent nonprofit research
organization, on behalf of a public health agency. RTI is working with Research Now to conduct this
survey but is not affiliated with Research Now in any way.
Possible Risks or Discomforts
There are no known risks to participating in this study. Although the survey questions we ask are not
meant to be sensitive, there is always a chance that you may feel uncomfortable with some of the
questions. You do not have to answer any question that you don’t want to answer. There is also a
potential risk of loss of confidentiality. Every effort will be made to protect your information, but this cannot
be guaranteed.
Benefits
There are no individual benefits for participants. However, your responses are very important because
they will help researchers understand how people make decisions about medications.
Confidentiality
As with other surveys you receive from Research Now, the privacy and confidentiality of your information
is of the highest importance, and we are committed to maintaining a secure environment in which you can
participate. All information collected in this survey will be kept confidential to the extent provided by law.
Your name and your email address will not be shared outside of Research Now, and they will not be
associated with your answers or used in any report. The information obtained from all of the surveys will
be combined into a summary report so that details of individual questionnaires cannot be linked to a
specific participant. You will not be recontacted about this research study in the future.
Reimbursement
In appreciation for your time, you will receive {$5.00 in e-Rewards Currency / an honorarium of $27.00}
for completing the survey.
Right to Refuse or Withdraw
Your participation in this study is completely voluntary, and you can withdraw from the study for any
reason at any time without penalty.
Persons to Contact

5

Last edited: June 30, 2017

If you have questions about this survey, please contact Member Services at http://www.erewards.com/contactus.do, and someone will direct your questions to the appropriate researchers at RTI.
If you have questions about your rights as a participant, you can call RTI’s Office of Research Protection
toll-free at 1-866-214-2043.
[----------------------------------------New screen----------------------------------------]
[SINGLE PUNCH]
Consent. If you have read the previous screens and agree to participate, please click the Yes button. If
not, click the No button.
1

Yes, I agree to participate.

[Go to ‘Randomization’]

2

No, I do not agree to participate.

[End survey]

[PROGRAMMER: IF CONSENT = 1 ‘Yes’, GO TO ‘Randomization’]
[PROGRAMMER: IF CONSENT !== 1 ‘Yes’, SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE]
[PROGRAMMER: Randomly assign participants to one of three experimental conditions.
Record assignment in variable XCONDITION with possible values 1 ‘None’, 2 ‘Few, OR 3
‘Many’.
USE PURE RANDOM ASSIGNMENT TO ASSIGN PARTICIPANTS TO EXPERIMENTAL
CONDITION. DO NOT USE LEAST-FILLS. DO NOT CAP.]
[----------------------------------------New screen----------------------------------------]
[DISPLAY ‘Intro screen 1’ IF EFLAG=1 ‘ELIGIBLE’]
Before continuing, here are some helpful tips for taking the survey:
 You may skip any question you do not want to answer. If you do skip a question, red text will
appear to let you know that the question was skipped. If that question was accidentally left blank,
then you can provide an answer before moving to the next page.
 Once you have moved to the next page in the survey, you will not be able to return to the
previous page.
 Keep in mind that you may need to scroll to see all the items on a page.
 Make sure you are comfortable and can read the screen from where you sit.
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
You are among a small group of people selected to take part in this study and your responses are
very important.
On the next screen, we will ask you to look at a picture of a website that is under
development for a new prescription drug.
The researchers are looking at how {people / providers} think about drug information. It is part of
an effort to make drug websites more helpful. We are not connected with the drug being
promoted, so please give us your honest reaction to the information on the website.

6

Last edited: June 30, 2017

Carefully read website to see what you think and feel about it. After you finishing viewing it, we
will ask you some questions about what you saw.
[----------------------------------------New screen----------------------------------------]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 1 ‘None’, DISPLAY IMAGE: CID_S1_Cons_1.jpg
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 2 ‘Few’, DISPLAY IMAGE: CID_S1_Cons_2. jpg
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 3 ‘Many’, DISPLAY IMAGE: CID_S1_Cons_3. jpg
IF COHORT = 2 ‘PCP’ AND XCONDITION = 1 ‘None’, DISPLAY IMAGE: CID_S1_PCP_1. jpg
IF COHORT = 2 ‘PCP’ AND XCONDITION = 2 ‘Few’, DISPLAY IMAGE: CID_S1_PCP_2. jpg
IF COHORT = 2 ‘PCP’ AND XCONDITION = 3 ‘Many’, DISPLAY IMAGE: CID_S1_PCP_3. jpg]
[Please disable the “Next” button for 5 seconds]
Please click the ‘Next’ button to continue. Once you leave this screen you will not be able to return to it.
[----------------------------------------New screen----------------------------------------]
[SQUIRCLES: TEN TEXTBOXES]
What are the risks and side effects of [DRUG]? Please list as many risks and side effects as you can
remember. Use one box for each risk or side effect you list. Use your mouse to move to the next box. You
do not need to fill out every box.

[----------------------------------------New screen----------------------------------------]
[GRID: SINGLE PUNCH]

7

Last edited: June 30, 2017

Based only on the information in the [DRUG] website, please check if any of the following were
mentioned as a side effect or a risk of taking [DRUG].
Mentioned in
Not mentioned
the website
in the website
PROGRAMMER: RANDOMIZE ORDER OF ITEMS Q2_a – Q2_i]
1
2
Q2_a. Constipation
1
2
Q2_b. Dry mouth
1
2
Q2_c. Headache
1
2
Q2_d. Serious mental and mood changes
1
2
Q2_e. Decreased sexual ability or desire
1
2
Q2_f. Numbness or tingling of hands or feet
1
2
Q2_g. Glaucoma or other changes in vision
1
2
Q2_h. {Decreased liver function / Hepatic failure}
1
2
Q2_i. {Swelling of ankles or legs / Lower extremity edema}
1
2
[----------------------------------------New screen----------------------------------------]
To what extent do you believe these statements are true or false?
Click and drag the square to a point on the scale that best reflects your opinion.
Q3A.

[DRUG] is a risk-free option for managing chronic pain.

Definitely false

Definitely true
1

Q3B.

2

3

4

5

6

[DRUG] provides safe and complete relief from chronic pain.

Definitely false

Definitely true
1

2

3

4

5

6

[----------------------------------------New screen----------------------------------------]
[MULTIPLE PUNCH]
Q3. This question asks about information that may or may not have been in the [DRUG] website.
Which of these statements, if any, were in the website? If you think a statement was in the website,
click on that box to select it. Select all that apply.
[PROGRAMMER: RANDOMIZE ORDER EXCEPT FOR “NONE OF THE ABOVE”]
Q3_1. “[DRUG] is the only prescription medication that contains dolafaxine as an active ingredient.”
Q3_2. “No head-to-head clinical trials have demonstrated that [DRUG] is more effective than any
other SNRI for treating body or joint pain caused by muscle strain, arthritis, and other
conditions.”
Q3_3. “[DRUG] is available only by prescription for adults 18 or over who suffer from chronic pain.”
Q3_5. “[DRUG] is the number one prescribed chronic pain drug.”
Q3_7. “[DRUG] is the first and only pain reliever that is FDA-approved to treat both chronic pain
and restless leg syndrome.”
Q3_8. None of the above.
[PROGRAMMER: IF Q3_8 = 1 ‘Selected’, DISABLE OPTIONS Q3_1 – Q3_7]

8

Last edited: June 30, 2017

[----------------------------------------New screen----------------------------------------]
[SLIDERS; RANDOMIZE ITEM ORDER Q4 – Q11]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects your opinion of the website.
I felt the website was…
Q4.
Confusing

Q5.

Q6.

Clear
1

2

3

4

5

6

1

2

3

4

5

6

Bad

Good

Uninformative

Informative
1

Q7.

6

2

3

4

5

6
Believable

2

3

4

5

6

Inaccurate

Accurate
2

3

4

5

6

False

Factual
1

Q11.

5

Not believable

1
Q10.

4

Interesting

1
Q9.

3

Boring
1

Q8.

2

2

3

4

5

6

Misleading

Honest
1

2

3

4

5

6

[PROGRAMMER: IF COHORT = 1 ‘Consumer’ SKIP Q12_P, GO TO Q12_C_1]
[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
[ASK Q12_P IF COHORT = 2 ‘PCP’]
Q12_P. If I had a patient with chronic pain, I would consider prescribing [DRUG].
Strongly disagree
1
2
3
4
5
6

Strongly agree

[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP Q12_C_1 AND Q12_C2, GO TO Q13]
[PROGRAMMER: IF S6_C = 1 ‘Currently taking’, SKIP Q12_C_1, GO TO Q12_C_2]
[ASK Q12_C_1 IF COHORT = 1 ‘Consumer’ AND S6_C !== 1 ‘Currently taking’]

9

Last edited: June 30, 2017

Q12_C_1. If I were to take a prescription drug for my chronic pain, I would consider taking [DRUG].
Strongly disagree
Strongly agree
1
2
3
4
5
6
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S6_C !== 1 ‘Currently taking’, SKIP
Q12_C_2, GO TO Q13]
[ASK Q12_C_1 IF S6_C = 1 ‘Currently taking’]
Q12_C_2. I would consider switching to [DRUG].
Strongly disagree
1
2
3

Strongly agree
4

5

6

[PROGRAMMER: GO TO Q13]
[----------------------------------------New screen----------------------------------------]
[SLIDERS]
Q13. [DRUG] is safer than other prescription drugs that treat chronic pain.
Strongly disagree
1
2
3
4
5
6

Strongly agree

Q14. [DRUG] is more effective than other prescription drugs that treat chronic pain.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q15. I would be very worried about {experiencing / my patients experiencing} side effects if {I / they}
took [DRUG].
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q16. The website exaggerates the benefits of [DRUG].
Strongly disagree
1
2
3
4

Strongly agree
5

6

[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects your opinion.
Q17. How likely are you to look for more information about [DRUG]?
Not at all likely
1
2
3
4
5
Q18.

Extremely likely
6

If one of your {family members or close friends / patients} were considering using a prescription
drug to help with moderate to severe chronic pain, how likely are you to mention [DRUG] to
him/her?
Not at all likely
Extremely likely

10

Last edited: June 30, 2017

1

2

3

4

5

6

Q19. Would this website mislead people about the effectiveness of [DRUG]?
No, definitely not
1
2
3
4
5
6

Yes, definitely

Q19b. Would this website mislead people about the risks of [DRUG]?
No, definitely not
1
2
3
4
5

Yes, definitely
6

[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
Q20.

I like the overall design of the website.

Strongly disagree

Strongly agree
1

2

3

4

5

6

Q22. The information on the website was relevant to me.
Strongly disagree
1
2
3
4

5

6

Q23. The website tried to minimize the side effects of [DRUG].
Strongly disagree
1
2
3
4

5

6

Q24. How carefully did you read the [DRUG] website?
I skimmed the
website
1
2
3
4

Strongly agree

Strongly agree

I read the
website carefully
5

6

[----------------------------------------New screen----------------------------------------]
[SLIDERS; RANDOMIZE ITEM ORDER Q25 – Q27]
[DISPLAY]
Please tell us how you feel about [DRUG].
Click and drag the square to a point on the scale that best reflects your opinion of [DRUG].
To me, [DRUG] is…
Q25.
A bad option

A good option
1

2

3

11

4

5

6

Last edited: June 30, 2017

Q26.

Q27.

Harmful

Helpful
1

2

3

4

5

6

1

2

3

4

5

6

Useless

Useful

[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects your opinion.
[RANDOMIZE ORDER OF ITEMS Q28 – Q29]
Q28. How likely is it that [DRUG] would relieve {your / your patients’} chronic pain if {you / they} took it?
Not at all likely
Extremely likely
1
2
3
4
5
6
Q29. If {I / my patients} took [DRUG], it would completely eliminate {my / their} chronic pain.
Strongly disagree
Strongly agree
1
2
3
4
5
6
[----------------------------------------New screen----------------------------------------]
[Consumer image]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 1 ‘None’, DISPLAY IMAGE:
CID_S1_Cons_1.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 2 ‘Few’, DISPLAY IMAGE:
CID_S1_Cons_2.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 3 ‘Many’, DISPLAY IMAGE:
CID_S1_Cons_3.pdf
]
[Provider image]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 2 ‘PCP’ AND XCONDITION = 1 ‘None’, DISPLAY IMAGE: CID_S1_PCP_1.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 2 ‘Few’, DISPLAY IMAGE: CID_S1_PCP_2.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 3 ‘Many’, DISPLAY IMAGE: CID_S1_PCP_3.pdf
]
[HOT SPOT COLLECTOR: CATEGORY SELECTION W/PREDEFINED AREAS & VERBATIM]
[DISPLAY]
[DISPLAY]
Now we are going to show you the same website you saw at the start of the survey.

12

Last edited: June 30, 2017

Click on any part of the website you think is inaccurate. If you do not think there is anything that is
inaccurate, select “None” above the image.
[PROGAMMER: For each hot spot region clicked within the image, participant will be
asked….]
What makes this inaccurate?

[----------------------------------------New screen----------------------------------------]
[MULTIPLE PUNCH]
Q31. If you saw a website or ad for a prescription drug that you thought was misleading or dishonest,
what would you do? Select all that apply.
Q31_1. I would not do anything.
Q31_2. I would contact the drug company.
Q31_3. I would contact the U.S. Food and Drug Administration (a federal government agency).
Q31_4. I would {tell my doctor or pharmacist / discuss it with my colleagues}.
Q31_5. I would talk to my family or friends.
Q31_6. I would post about it on social media.
Q31_8. I would discourage others from using the drug.
Q31_7. Other
[TEXTBOX] Q31_7_Open.__________________
[PROGRAMMER: IF Q31_7 = 1 ‘Selected’, ENABLE TEXTBOX FOR Q31_7_Open]
[----------------------------------------New screen----------------------------------------]
[SLIDER]
Q32. If there was a way to report misleading prescription drug websites or ads to the Food and Drug
Administration (FDA) by sending an e-mail or calling a toll-free phone number, how likely would you
be to report misleading material?

Not at all likely

Extremely likely
1

2

3

4

5

6

[SLIDER]
Q33. Thinking about the website that you saw, do you think it should be reported to the FDA as a
potentially misleading website?
No, definitely not

Yes, definitely
1

2

3

4

5

[----------------------------------------New screen----------------------------------------]
[DISPLAY]

13

6

Last edited: June 30, 2017

The FDA’s "Bad Ad" program is an outreach effort to educate healthcare providers about the role they
can play in helping the FDA make sure that prescription drug ads and promotion are truthful and not
misleading. The program is designed to help healthcare providers recognize misleading prescription drug
promotion and provide them with an easy way to report misleading information to the FDA (via phone,
877-RX-DDMAC, or email, [email protected]).

Q34.
1
2
998

[SINGLE PUNCH]
Were you aware of this program?
Yes
No
Don’t know/Not sure

Q35.
1
2
998

[SINGLE PUNCH]
Do you think the Bad Ad program should be expanded to consumers?
Yes
No
Don’t know/Not sure

[----------------------------------------New screen----------------------------------------]
[NUMERICAL FIELD; SET RANGE 0 – 10]
Q36. Rate your current knowledge about prescription drugs that treat chronic pain on a scale of 0 to 10,
where 0 means knowing nothing and 10 means knowing everything you could possibly know about
the topic. _____
[PROGRAMMER: IF COHORT = 1 ‘CONSUMER’, SKIP Q36b, GO TO Q37]
Q36b. Approximately what proportion of your current patients do you treat for chronic pain?
1 None or very few
2 A small proportion
3 About one-half
4 A large proportion
5 Everyone or almost everyone
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
We are now done asking you about the website that you looked at today.
We would like to ask you about your personal views on {prescription drug websites / physiciantargeted prescription drug websites} in general. These are statements other people have made about
prescription drug websites.
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
[SLIDERS; RANDOMIZE ORDER OF ITEMS Q37 – Q39e]
Q37. Prescription drug websites are a reliable source of information about the quality and performance of
medications.
Strongly disagree
Strongly agree

14

Last edited: June 30, 2017

1

2

3

4

5

6

Q38. I feel I’ve been accurately informed after seeing most prescription drug websites.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q39. In general, prescription drug websites present a true picture of the drug being advertised.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q39a. We can depend on getting the truth in most prescription drug websites.
Strongly disagree

Strongly agree
1

2

3

4

5

6

Q39b. Prescription drug website’s aim is to inform {consumers / providers}.
Strongly disagree

Strongly agree
1

2

3

4

5

6

4

5

6

Q39c. Prescription drug websites are informative.
Strongly disagree

Strongly agree
1

2

3

Q39d. Most prescription drug websites provide {consumers / providers} with essential information.
Strongly disagree

Strongly agree
1

2

3

4

5

6

Q39e. It bothers me when prescription drug websites make a drug seem better than it really is.
Strongly disagree

Strongly agree
1

2

3

4

5

6

[----------------------------------------New screen----------------------------------------]
Q39f. FDA must approve prescription drug websites before they appear online.
1 True
2 False
3 Don’t know
[----------------------------------------New screen----------------------------------------]
[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP Q39g, GO TO ‘Q40_P’]
Q39g. In what situations, would you consider taking prescription drugs?
1
2
3
4

I would never take them
I would take them only for serious health conditions
I would take them for moderate and serious health conditions
I would take them for most health conditions, including minor problems

15

Last edited: June 30, 2017

[PROGRAMMER: IF COHORT = 1 ‘Consumer’, SKIP Q40_P – Q42_P, GO TO ‘CONSUMER
DEBRIEF SCREEN’]
[----------------------------------------New screen----------------------------------------]
[ASK Q40_P – Q42_P IF COHORT = 2 ‘PCP’]
[NUMERICAL FIELD]
Q40_P. Since completing your residency, how many years have you been a healthcare provider?
_____ years
[SINGLE PUNCH]
Q41_P. Have you received any formal training regarding pharmaceutical marketing (e.g., lectures,
presentations, classes, or computerized training)?
1 Yes
2 No
3 Don’t remember
[SINGLE PUNCH]
Q42_P. Have you received any informal training regarding pharmaceutical marketing (e.g., instructions
from a mentor regarding how to address direct-to-consumer advertising questions from a
patient)?
1 Yes
2 No
3 Don’t remember
[PROGRAMMER: IF COHORT = 2 ‘PCP’, GO TO ‘PROVIDER DEBRIEF SCREEN’]
[----------------------------------------New screen----------------------------------------]
[CONSUMER DEBRIEF SCREEN]
[DISPLAY IF COHORT = 1 ‘Consumer’]
You have been very helpful. Thank you very much for taking part in this survey!
The purpose of this study is to see whether consumers can identify false or misleading prescription drug
promotion and how likely consumers are to report such information to regulatory authorities, such as the
FDA. [DRUG] is a fake drug and is not a product currently for sale. Please see your healthcare
professional for questions about your health and your medical conditions.
[PROVIDER DEBRIEF SCREEN]
[DISPLAY IF COHORT = 2 ‘PCP’]
You have been very helpful. Thank you very much for taking part in this survey!
The purpose of this study is to see whether healthcare providers can identify false or misleading
prescription drug information and how likely providers are to report such information to regulatory
authorities. [DRUG] is a fictitious drug and is not a product currently for sale.

16


File Typeapplication/pdf
AuthorBoudewyns, Vanessa
File Modified2017-06-30
File Created2017-06-30

© 2024 OMB.report | Privacy Policy